BioLine RX Ltd. ADR | Ownership

Companies that own BioLine RX Ltd. ADR

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BVF Partners LP
25,995,575
24.06%
0
1.63%
06/30/2018
Senvest Management LLC
7,756,641
7.18%
-25,000
0.46%
06/30/2018
Medical Strategy GmbH
1,398,615
1.29%
28,800
0.7%
11/30/2017
Apo Asset Management GmbH
1,165,551
1.08%
0
0.04%
06/29/2018
OrbiMed Advisors LLC
1,038,600
0.96%
0
0.01%
06/30/2018
Morgan Stanley & Co. LLC
1,010,585
0.94%
-115,984
0%
06/30/2018
Opaleye Management, Inc.
250,000
0.23%
0
0.06%
06/30/2018
Benchmark Capital Advisors, Inc.
143,000
0.13%
0
0.1%
06/30/2018
G1 Execution Services LLC
107,827
0.1%
107,827
0.01%
06/30/2018
Commonwealth Equity Services, Inc.
75,000
0.07%
0
0%
06/30/2018

About BioLine RX

View Profile
Address
Modi'in Technology Park
Modi'in TA 7177871
Israel
Employees -
Website http://www.biolinerx.com
Updated 07/08/2019
BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel.